Oncology Clinical Trial Expertise for Complex and High-Risk Development Programs

Ergomed helps biotech and biopharma sponsors simplify complexity and advance oncology trials with precision, speed, and confidence. From first-in-human studies to global pivotal programs, we combine scientific rigor, experienced project leadership, patient-guided execution, and a customer experience built for small and mid-size biotech teams.

Proven Oncology Trial Experience at Global Scale

Ergomed brings deep oncology experience across complex clinical development programs, supporting sponsors across diverse indications, geographies, and study designs. Our teams bring the therapeutic focus, operational discipline, and delivery model required to support complex oncology programs from early development through post-marketing.

500+
oncology studies
30,000+
oncology patients
3,800+
global sites

Recruitment, Feasibility, and Site-Centric Execution

In oncology, recruitment credibility is critical. Ergomed helps sponsors define realistic country and site strategies grounded in feasibility, indication complexity, competitive context, and operational readiness.

Our model combines recruitment analytics, KOL networks, and local site partnerships to support faster enrollment and stronger retention, even in rare and complex cancers.

Our site management approach is designed not only to monitor sites, but to actively support them from start-up and activation through recruitment, protocol compliance, and ongoing coordination, helping sites manage complexity with greater confidence.

Critical Success Factors for Oncology Study Management

Medical support for complex oncology protocols

Ergomed supports complex oncology studies with experienced medical and operational leadership, particularly in first-in-human development, dose escalation, adaptive designs, umbrella studies, and basket trials. Our teams help align study strategy, site support, and operational delivery for protocols that demand close coordination and strong oversight.

Feasibility and recruitment strength in difficult indications

We combine recruitment analytics, KOL networks, and site partnerships to support faster enrollment and stronger retention, helping sponsors build more realistic country and site strategies from the outset.

Patient-guided execution that strengthens retention

Our patient-first operating model is designed to improve the trial experience for patients and sites while supporting continuity of care, protocol adherence, and retention. This patient-guided approach is central to how Ergomed CARE™ helps translate oncology expertise into stronger operational performance.

Integrated delivery across the trial lifecycle

Through integrated oncology consulting and operational delivery, Ergomed helps sponsors navigate regulatory complexity, optimize trial design, and align recruitment, start-up, and execution strategy across the study lifecycle. Our experts act as strategic advisors as well as delivery partners.

Focused Expertise in Head & Neck Oncology

Head and neck oncology trials require a CRO that understands both the scientific complexity of the indication and the operational demands of successful delivery across sites and geographies.

These studies often involve heterogeneous patient populations, complex treatment pathways, demanding endpoints, and recruitment and retention challenges that require close coordination between sponsors, investigators, and sites. Ergomed brings the therapeutic depth, medical support, and pragmatic delivery model needed to help sponsors advance head and neck oncology studies with greater confidence.

Early-Phase Oncology

Ergomed supports early-phase oncology development with expertise in first-in-human and dose-escalation studies, including adaptive, umbrella, and basket trial designs. We help sponsors bring greater structure, speed, and clinical focus to studies where close coordination and rapid decision-making are essential.

Immuno-Oncology

Ergomed brings experience across checkpoint inhibitors, CAR-T, T-cell engagers, cancer vaccines, and novel immunotherapies. Our teams support these programs with biomarker-driven strategies, strong safety oversight, and the operational coordination needed for increasingly complex immuno-oncology development.

Cell and Gene Therapy (ATMPs)

Ergomed provides end-to-end support for advanced therapy programs, including cryogenic logistics, regulatory strategy, and long-term patient follow-up. We help sponsors navigate the unique operational, clinical, and safety challenges associated with cell and gene therapy development from early-phase planning through later-stage execution.

Oncology Expertise Across the Full Development Pathway

Our oncology portfolio spans the full clinical development lifecycle, from early signal-seeking and dose-escalation studies through pivotal and post-marketing programs.

  • Speed, precision, and close cross-functional coordination for first-in-human and early signal-seeking studies.

VP, Global Medical Affairs

Dusan Markovic, MD

Dr. Dusan Markovic

Dr. Markovic brings deep oncology expertise across medical affairs, medical monitoring, study physician roles, and complex protocol support. His experience spans oncology development from Phase I through Phase IV, including programs in glioblastoma, NSCLC, HNSCC, CRC, and HCC.

He has contributed to study design and oncology development strategy across a wide range of complex programs and has co-authored abstracts for major oncology congresses including ASCO, ESMO, ECHNO, and ESTRO.

  • 20+ years of oncology clinical development focus
  • Experience across Phase I–IV oncology studies
  • Deep exposure to glioblastoma, NSCLC, HNSCC, CRC, and HCC
  • Protocol design input for numerous complex oncology trials

Looking for an oncology CRO built for complexity, collaboration, and execution?

Whether you are advancing a rare tumor therapy, planning a first-in-human oncology study, or scaling a global immuno-oncology program, Ergomed is built to help you simplify complexity, deliver decision-ready data, and move faster with confidence.

Oncology Expertise, Ergo, Deep Understanding

Contact Us

Our Complementary Services

See how Ergomed can support your clinical trial.

More Ergomed Services

Find out how Ergomed supports your clinical trial objectives.